Argon to pay $362.5M for Angiotech's interventional biz

Argon Medical Devices has agreed to pay $362.5 million to acquire Angiotech Pharmaceuticals' interventional products unit. The cash deal, set to be finalized by the end of next month, covers Angiotech's drainage catheters, biopsy systems and related products.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID